Drug
E2007
E2007: highest development phase Phase 3, developed by Eisai. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| E2007 NCT03201900 | Phase 3 | Partial Onset Seizures |
| E2007 (perampanel) NCT00699582 | Phase 3 | Refractory Partial Seizures |
| E2007 NCT00416195 | Phase 2 | Epilepsy |
Latest
No recent events.
Follow E2007 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.